Relationship between Alzheimer disease - Like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers

Journal of Nuclear Medicine

Volumn 56, Issue 2, 2015, Pages 229-233

  Ishibashi, Kenji ^a   Onishi, Airin ^a   Fujiwara, Yoshinori ^a   Ishiwata, Kiichi ^a   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; FDG; PET; Precuneus, glucose

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE BLOOD LEVEL; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; VISUAL CORTEX; ANALYSIS; BRAIN; COGNITION; DIAGNOSTIC USE; IMAGE PROCESSING; MIDDLE AGED; NORMAL HUMAN; PATHOLOGY; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD GLUCOSE; BRAIN; COGNITION; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84922008094     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.150045     Document Type: Article

References (40)

1. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, et al. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med. 1995;36:1249-1254.
2. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280-292.
3. Kawasaki K, Ishii K, Saito Y, Oda K, Kimura Y, Ishiwata K. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med. 2008;22:191-200.
4. Burns CM, Chen K, Kaszniak AW, et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology. 2013;80:1557-1564.
5. 11C-PiB binding in a patient with mild cognitive impairment. J Alzheimers Dis. 2014;42:385-389.
6. 18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103-2110.
7. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology. 1992;183:643-647.
8. Hara T, Higashi T, Nakamoto Y, et al. Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging? Ann Nucl Med. 2009;23:657-669.
9. 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med. 1985;10:341-345.
10. Márián T, Balkay L, Fekete I, et al. Hypoglycemia activates compensatory mechanism of glucose metabolism of brain. Acta Biol Hung. 2001;52:35-45.
11. 18F]fluorodeoxyglucose. Methods. 2002;27:218-225.
12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
13. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270-279.
14. Ishii K. Clinical application of positron emission tomography for diagnosis of dementia. Ann Nucl Med. 2002;16:515-525.
15. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose, and lipids: does plasma insulin explain their relationships? Arteriosclerosis. 1987;7:197-202.
16. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999;68:179-186.
17. Grillo CA, Piroli GG, Hendry RM, Reagan LP. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 2009;1296:35-45.
18. Lucignani G, Namba H, Nehlig A, Porrino LJ, Kennedy C, Sokoloff L. Effects of insulin on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab. 1987;7:309-314.
19. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495.
20. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol. 2011;68:51-57.
21. Gandhe MB, M L, Srinivasan AR. Evaluation of body mass index (BMI) percentile cut-off levels with reference to insulin resistance: a comparative study on south Indian obese and non-obese adolescents. J Clin Diagn Res. 2013;7:1579-1582.
22. Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH. The role of default network deactivation in cognition and disease. Trends Cogn Sci. 2012;16:584-592.
23. Fransson P, Marrelec G. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis. Neuroimage. 2008;42:1178-1184.
24. Utevsky AV, Smith DV, Huettel SA. Precuneus is a functional core of the defaultmode network. J Neurosci. 2014;34:932-940.
25. Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006;129:564-583.
26. Musen G, Jacobson AM, Bolo NR, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012;61:2375-2379.
27. Soares JM, Sampaio A, Ferreira LM, et al. Stress impact on resting state brain networks. PLoS ONE. 2013;8:e66500.
28. 18F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983;7:590-598.
29. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol. 2004;55:306-319.
30. Sperling RA, Laviolette PS, O'Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63:178-188.
31. Wang L, Brier MR, Snyder AZ, et al. Cerebrospinal fluid Abeta42, phosphorylated Tau181, and resting-state functional connectivity. JAMA Neurol. 2013;70:1242-1248.
32. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007;4:147-152.
33. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis. 2012;30(suppl 2):S185-S198.
34. Xu W, Qiu C, Winblad B, Fratiglioni L. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes. 2007;56:211-216.
35. American-Diabetes-Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(suppl 1):S37-S42.
36. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
37. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108-1112
38. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
39. Di Bonito P, Di Fraia L, Di Gennaro L, et al. Impact of impaired fasting glucose and other metabolic factors on cognitive function in elderly people. Nutr Metab Cardiovasc Dis. 2007;17:203-208.
40. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63:658-663.